Trial Profile
Phase 3 study of EPOCH to maintain hemoglobin levels in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2022
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 16 Jun 2016 New trial record